FDA approves another new migraine medicine

The Food and Drug Administration has approved Reyvow, a new pill made by Eli Lilly that treats migraine attacks. The drugmaker did not immediately disclose the drug's price.

The big picture: Reyvow is not approved for the prevention of migraines, but other new drugs on the market — Aimovig, Ajovy and Emgality — are described as preventative for migraines.